Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
E-posTErs<br />
E-Posters<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 246 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
> Hypofractionated accelerated radiotherapy by simultaneous integrated<br />
boost for high risk breast cancer patients<br />
N. Rodríguez Ibarria (Spain), A. Cabezón, L. García, A. Riveros,<br />
M. Lloret, I. Ramírez, L.A. Henríquez-Hernández, A. Valenciano,<br />
P.C. Lara EP-1014<br />
> Radiotherapy and adjuvant trastuzumab for HER-2 breast cancer:<br />
clinical outcome and cardiotoxicity<br />
L. Vinante (Italy), L. Evangelista, O. Lora, F. Berti, A. Banzato,<br />
L. Baboci, D. Fiore, G. Sotti EP-1015<br />
> Heart and cardiac chambers dose following 4-field radiation<br />
therapy of breast cancer - a retrospective study<br />
S. Johansen (Norway) EP-1016<br />
> Hypofractionation with simultaneous integrated boost for stage I-II<br />
breast cancer, randomized clinical trial<br />
H. Van Parijs (Belgium), G. Miedema, V. Vinh-Hung, S. Verbanck,<br />
N. Adriaenssens, D. Kerkhove, T. Reynders, G. Storme, D. Verellen,<br />
M. De Ridder EP-1017<br />
> Phase III study comparing accelerated partial breast irradiation vs<br />
whole breast radiation therapy using 3D-CRT<br />
N. Rodriguez (Spain), X. Sanz, P. Foro, A. Reig, I. Membrive,<br />
J. Lozano, E. Fernández-Velilla, J. Quera, O. Pera, M. Algara EP-1018<br />
ElECTroniC posTEr: CliniCAl TrACK: Cns And hAEMAToloGy<br />
> Favorable outcomes of adjuvant radiotherapy for intracranial<br />
ependymoma; a single institution experience<br />
H. Cha (Korea Republic of), J. Cho, D. Kim, C. Suh EP-1019<br />
> Splenic radiothreapy implemantation for splenomegaly in a patient<br />
with chronic myeloid leukemia (CML)<br />
H. Bas Ayata (Turkey), M. Guden, N. Kucuk, C. Ceylan, A. Kiliç,<br />
K. Engin EP-1020<br />
E-Posters<br />
abS. numbER<br />
> Single centre report on treatment of anaplastic astrocitomas withr<br />
radiotherapy plus temozolamide<br />
M. Nagliati (Italy), E. Magri, S. Brugnara, E. Colarusso,<br />
M. Barbareschi, F. Chioffi, L. Tomio EP-1021<br />
> Management of primary central nervous system lymphoma (PCNSL).<br />
A single UK centre experience<br />
M.Z. Saipillai (United Kingdom), F. Azam, M. Anthonypillai,<br />
S. Khakoo, F. Latif, H. Wong, B. Haylock EP-1022<br />
> Treatment outcomes in GBM – validation of results of a randomised<br />
phase III clinical trial in a non trial population<br />
K. Rock (Ireland Republic of), O. McArdle, P. Forde, M. Dunne,<br />
B. O’Neill, C. Faul EP-1023<br />
> Bevacizumab in combination with CPT-11 for recurrent high glioma.<br />
Experience of use in our centre<br />
V. Isabel (Spain), D.I.A.Z. Laura, M. Ernesto, G. Esther,<br />
D.I.A.Z. Veronica, P. Dolores, G. Lucia, S. Carmen, A. Enrique EP-1024<br />
> Rescue treatment for high grade gliomas through hypofractionated<br />
RT+ Bevacizumab. Experimental study<br />
V. González Vidal (Spain), A. Conde Moreno, P. Almendros,<br />
R. De Las Peñas Bataller, C. Ferrer Albiach EP-1025<br />
> Role of percent response evaluation criteria after first-line<br />
chemotherapy in combined therapy Hodgkin lymphoma<br />
P.V. Datsenko (Russian Federation), V.A. Gombolevskii,<br />
P.M. Kotlayrov, G.A. Panshin EP-1026<br />
> New RPA-classification (adapted version RSCRR) for brain tumors<br />
grade 3-4<br />
T.R. Izmailov (Russian Federation), G.A. Panshin, P.V. Datsenko EP-1027<br />
> The role of radiotherapy in the management of POEMS syndrome<br />
J. Cho, Y. Kim (Korea Republic of), C. Suh EP-1028<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 247<br />
E-posTErs<br />
eSTRO 31
Change language